| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
0.75 |
? － ? |
Quinupristin/Dalfopristin (Synercid)  |
1112 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
1.5 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
3 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
9 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + ampicillin-resistant) |
0.5 |
2 |
0.25 － 8 |
Cefquinome |
1486 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + ampicillin-resistant) |
0.5 |
2 |
0.25 － 16 |
Cefpirome |
1486 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + ampicillin-resistant) |
1 |
8 |
0.5 － 64 |
Cefepime (Maxipime) |
1486 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + ampicillin-resistant) |
8 |
32 |
4 － 32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1486 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + non-Staphylococcus epider) |
1 |
1 |
0.5 － 2 |
Eperezolid (PNU-100592) |
33 |
| Staphylococcus (coagulase-negative + methicillin-susceptible + non-Staphylococcus-epider) |
1 |
1 |
0.13 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
11 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
0.28 |
≤0.008 － 0.6 |
Dalbavancin |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
0.28 |
? － ? |
Dalbavancin |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
0.375 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
0.5 |
? － ? |
Daptomycin (Cubicin) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus (coagulase-negative + methicillin-susceptible) |
- |
5 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Staphylococcus (coagulase-negative + non-Staphylococcus-epidermidis + methicillin-resist) |
1 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
| Staphylococcus (coagulase-negative + non-Staphylococcus-epidermidis + methicillin-suscep) |
1 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
| Staphylococcus (coagulase-negative + oxacillin-resistant) |
>0.25 |
>16 |
≤0.12 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
| Staphylococcus (coagulase-negative + oxacillin-resistant) |
>16 |
>16 |
≤0.12 － >16 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
18 |
| Staphylococcus (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.12 － >16 |
Clindamycin (Cleocin) |
18 |
| Staphylococcus (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.5 |
≤0.12 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
| Staphylococcus (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>16 |
≤0.12 － >16 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
18 |
| Staphylococcus (coagulase-negative + teicoplanin-resistant) |
- |
0.25 |
0.03 － 0.25 |
Dalbavancin |
1112 |
| Staphylococcus (coagulase-negative + teicoplanin-resistant) |
- |
1 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
| Staphylococcus (coagulase-negative + teicoplanin-resistant) |
- |
1 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
1112 |
| Staphylococcus (coagulase-negative + teicoplanin-resistant) |
- |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus (coagulase-negative + teicoplanin-resistant) |
- |
- |
0.25 － ? |
Dalbavancin |
1112 |